Both in Pharmaceuticals
Alto Neuroscience vs Jade Biosciences
Over the past year ANRO returned +87.0% and JBIO returned +42.1%; their daily moves had a correlation of 0.39.
ANRO +87.0% JBIO +42.1%Growth of $1, one year, split-adjusted
| Metric | ANRO | JBIO |
|---|---|---|
| Price | $22.91 | $14.48 |
| Market cap | $898.8M | $920.9M |
| Today | −1.23% | −1.76% |
| 1 month | −13.8% | +2.1% |
| 6 months | −5.7% | −35.1% |
| Year to date | +28.7% | −6.2% |
| 1 year | +87.0% | +42.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.1M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | 51.9% |
| Short % of float | 20.0% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).